Belmont Global Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Belmont Global Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-60,000	Closed	-$960K	–	95
2016 Q2	$960K	Buy	60,000 +10,000	+20%	+$179K	0.92%	19
2016 Q1	$1.04M	Buy	50,000 +12,478	+33%	+$223K	1.06%	22
2015 Q4	$1.01M	Buy	37,522 +2,522	+7%	+$68.8K	1.31%	21
2015 Q3	$973K	Sell	35,000 -15,000	-30%	-$473K	1.65%	15
2015 Q2	$1.23M	Sell	50,000 -121,600	-71%	-$2.51M	1.36%	14
2015 Q1	$3.14M	Sell	171,600 -13,500	-7%	-$274K	3.19%	6
2014 Q4	$3.42M	Sell	185,100 -26,800	-13%	-$318K	3.37%	4
2014 Q3	$2.04M	Buy	211,900 +76,900	+57%	+$766K	1.6%	17
2014 Q2	$1.24M	Sell	135,000 -50,000	-27%	-$456K	0.89%	30
2014 Q1	$2M	Buy	+185,000	New	+$1.82M	1.68%	16

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Belmont Global Advisors's LJPC Position: Q3 2016 in Review

Belmont Global Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2016, closing a stake of 60,000 shares — an estimated $960K sold.

Belmont Global Advisors first reported a position in LJPC in Q1 2014 and held it in 10 quarters. The position peaked at $3.42M in Q4 2014. 71 funds tracked by Wall St. Rank hold LJPC as of Q3 2016.

Belmont Global Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q3 2016 after selling out during the quarter.
Belmont Global Advisors sold 60,000 La Jolla Pharmaceutical Company shares in Q3 2016, an estimated $960K.
Belmont Global Advisors first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 10 quarters.
Belmont Global Advisors's La Jolla Pharmaceutical Company position peaked at $3.42M in Q4 2014.
71 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.